Advertisement

Index by author

June 01, 2024; Volume 389,Issue 3

  1. Maffuid, Kaitlyn

    1. Utilizing a Proximity Dependent Labeling Strategy to Study Cancer-Immune Intercellular Interactions In Vitro and In Vivo
      Kaitlyn Maffuid and Yanguang Cao
      Journal of Pharmacology and Experimental Therapeutics June 2024, 389 (3) 246-253; DOI: https://doi.org/10.1124/jpet.123.001761

  2. Meqbil, Yazan J.

    1. Identification of 1,3,8-Triazaspiro[4.5]Decane-2,4-Dione Derivatives as a Novel <em>δ</em> Opioid Receptor-Selective Agonist Chemotype
      Identification of 1,3,8-Triazaspiro[4.5]Decane-2,4-Dione Derivatives as a Novel δ Opioid Receptor-Selective Agonist Chemotype
      Yazan J. Meqbil, Jhoan Aguilar, Arryn T. Blaine, Lan Chen, Robert J. Cassell, Amynah A. Pradhan and Richard M. van Rijn
      Journal of Pharmacology and Experimental Therapeutics June 2024, 389 (3) 301-309; DOI: https://doi.org/10.1124/jpet.123.001735

  3. Nizet, Victor

    1. The Prospect of Biomimetic Immune Cell Membrane-Coated Nanomedicines for Treatment of Serious Bacterial Infections and Sepsis
      Alexandria Hoffman and Victor Nizet
      Journal of Pharmacology and Experimental Therapeutics June 2024, 389 (3) 289-300; DOI: https://doi.org/10.1124/jpet.123.002095

  4. Pleil, Kristen E.

    1. A Little “Re-Cognition” Goes a Long Way for Pro-Cognitive Therapeutics in Alcohol Studies
      Michael C. Salling and Kristen E. Pleil
      Journal of Pharmacology and Experimental Therapeutics June 2024, 389 (3) 254-257; DOI: https://doi.org/10.1124/jpet.123.002058

  5. Pradhan, Amynah A.

    1. Identification of 1,3,8-Triazaspiro[4.5]Decane-2,4-Dione Derivatives as a Novel <em>δ</em> Opioid Receptor-Selective Agonist Chemotype
      Identification of 1,3,8-Triazaspiro[4.5]Decane-2,4-Dione Derivatives as a Novel δ Opioid Receptor-Selective Agonist Chemotype
      Yazan J. Meqbil, Jhoan Aguilar, Arryn T. Blaine, Lan Chen, Robert J. Cassell, Amynah A. Pradhan and Richard M. van Rijn
      Journal of Pharmacology and Experimental Therapeutics June 2024, 389 (3) 301-309; DOI: https://doi.org/10.1124/jpet.123.001735

  6. Saldana, Santiago J.

    1. Cognitive-Enhancing Effects of Acetylcholine Receptor Agonists in Group-Housed Cynomolgus Monkeys Who Drink Ethanol
      Lindsey K. Galbo-Thomma, Phillip M. Epperly, Bruce E. Blough, Antonio Landavazo, Santiago J. Saldaña, F. Ivy Carroll and Paul W. Czoty
      Journal of Pharmacology and Experimental Therapeutics June 2024, 389 (3) 258-267; DOI: https://doi.org/10.1124/jpet.123.001854

  7. Salling, Michael C.

    1. A Little “Re-Cognition” Goes a Long Way for Pro-Cognitive Therapeutics in Alcohol Studies
      Michael C. Salling and Kristen E. Pleil
      Journal of Pharmacology and Experimental Therapeutics June 2024, 389 (3) 254-257; DOI: https://doi.org/10.1124/jpet.123.002058

  8. Sheets, Patrick L.

    1. Open Access
      Targeting Prefrontal Cortex Dysfunction in Pain
      Kai Kummer and Patrick L. Sheets
      Journal of Pharmacology and Experimental Therapeutics June 2024, 389 (3) 268-276; DOI: https://doi.org/10.1124/jpet.123.002046

  9. Tuske, Steve

    1. Comments on: Increasing Enzyme Mannose-6-Phosphate Levels but Not Miglustat Coadministration Enhances the Efficacy of Enzyme Replacement Therapy in Pompe Mice
      Jon J. Brudvig, Steve Tuske, Jeff Castelli and Jill M. Weimer
      Journal of Pharmacology and Experimental Therapeutics June 2024, 389 (3) 310-312; DOI: https://doi.org/10.1124/jpet.123.002014

  10. Van Rijn, Richard M.

    1. Identification of 1,3,8-Triazaspiro[4.5]Decane-2,4-Dione Derivatives as a Novel <em>δ</em> Opioid Receptor-Selective Agonist Chemotype
      Identification of 1,3,8-Triazaspiro[4.5]Decane-2,4-Dione Derivatives as a Novel δ Opioid Receptor-Selective Agonist Chemotype
      Yazan J. Meqbil, Jhoan Aguilar, Arryn T. Blaine, Lan Chen, Robert J. Cassell, Amynah A. Pradhan and Richard M. van Rijn
      Journal of Pharmacology and Experimental Therapeutics June 2024, 389 (3) 301-309; DOI: https://doi.org/10.1124/jpet.123.001735
« Previous (Pages : 1 2 3 4 ... 4) Next »
Back to top

In this issue

Advertisement